CPH, and oddly, you (well, it's not odd, we know exactly why...), keep pointing out things about the industry, without saying anything specific about the company.
Yes, this will change the industry, but that doesn't make CPH as an individual company profitable. Big pharma will no doubt profit from this. CPH holders will continue to see the value of their holdings dwindle.
Companies don't just automatically make money by attempting to enter into a market. They actually need a profitable business strategy. There are plenty of successful companies which actually make profits, which CPH isn't going to be able to compete with. It's doubtful they're even making a serious effort to try.
Add to My Watchlist
What is My Watchlist?